Here, we used previously published cMyBP-C peptides 302A and 302S21, surrogates of the regulatory phosphorylation site serine 302, as a tool to determine whether modulating the dephosphorylation state of cMyBP-C can improve cardiac contraction and relaxation in experimental heart failure (HF) models. Here, MYBPC3 is linked to heart failure.